ADAM FUKDSTIEN AND HIS SHORT HEDGE FRIENDS CAN COVER MONDAY
Over double digits. Fda approves Zenvia with a very friendly label. Avnr market cap will touch over a billion dollar by next week. I congratulate first the patients that are suffering from PBA than the company management for following the SPA protocol down to the finest detail. Finally, all longs that held through all the ups and downs know your award is finally here. Shorts and Bashturds I hope all of you rott in hell for shorting and bashing a tiny biotech that is bringing a drug for un met need of millions of PBA patients.
Hasta La Vista, The good doctor has left the building. Dr. Tony Montello.
I recall several months back Adam in one of his newsletters insisted that Chelsea Theraputics because they had changed the endpoints in their study for droxi that the FDA would never approve the new end points for their phase 3 study.... the FDA did approve a change in the endpoints and the study had a positive result... He managed to temporary knock the stock price down along with his short hedge fund buddys. Bottom line the stock moved from the low 2s after the thrashing to 7 bucks a share. Trust no one but your own DD.